Ben Goss on risk: Risk and retirement
Increasing mortality concerns, falling markets and disrupted spending patterns mean good retirement planning is more vital than ever
Author: Portfolio Adviser
-
-
‘Seek out balance’: WFH – with Premier Miton’s Ian Rees
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
Celebrating 10 years of the Hermes Global High Yield Credit Fund
To celebrate the 10-year anniversary of the Hermes Global High Yield Credit Fund, Fraser Lundie, Head of Credit at the international business of Federated Hermes, and Portfolio Adviser’s Group Editor Julian Marr, take a look at how the debt market has evolved over the last decade, how this has influenced the fund’s process and what part…
-
‘It feels like the victim is going to be the High Street’: Quarantine Q&A with JPMAM’s Joanna Kwok
JPM Asia Growth manager has been surprised by market rebound and divergence between winners and losers
-
‘Try to ‘disconnect’ for a day’: WFH – with JP Morgan WM’s Alejandro Gonzalez
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
‘We’re looking for consistency with the funds we hold’: Quarantine Q&A with Rathbone’s Emma Saunders
Rathbones senior research analyst reckons the speed of drawdowns has been impacted by increased quant and passive flows
-
Alternative Thinking: Seeing the good from the trees
In the latest in our occasional spotlights on less traditional assets, Olly Hughes highlights the uncorrelated nature and ESG credential of commercial forestry assets
-
‘Teach your children how to make tea’: WFH – with BMO Global AM’s Kelly Prior
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
Mark Northway: Move carefully in the land of falling knives
Steep market falls can put immense pressure upon investors but simple techniques can offer some protection
-
Graham Hooper: Target your biggest cyber weak spot – human error
Passwords, processes and systems can only protect us so far and the human factor is often the weakness
-
Alternative Thinking: The investment case for medical cannabis
In the first of an occasional spotlight on less traditional assets, Rahul Bhushan picks out the tailwinds supporting medical cannabis as an investment opportunity
-
Mark Preskett: This is a time to keep calm and see the positives
In this challenging environment, investors should put the significant market movements into perspective and remain level-headed